{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:22:41Z","timestamp":1793805761703,"version":"4.6.1"},"reference-count":158,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K08620"],"award-info":[{"award-number":["19K08620"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.resinv.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T07:41:07Z","timestamp":1671435667000},"page":"270-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases"],"prefix":"10.1016","volume":"61","author":[{"given":"Mutsuo","family":"Yamaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-0651","authenticated-orcid":false,"given":"Akiko","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.resinv.2022.11.002_bib1","doi-asserted-by":"crossref","first-page":"D59","DOI":"10.1016\/j.vaccine.2008.07.025","article-title":"Pathology of human influenza revisited","volume":"26","author":"Kuiken","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.resinv.2022.11.002_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1473-3099(19)30114-8","article-title":"Purulent bronchitis in 1917 and pandemic influenza in 1918","volume":"19","author":"Cox","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMoa0904252","article-title":"INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico","volume":"361","author":"Perez-Padilla","year":"2009","journal-title":"N Engl J Med"},{"issue":"1 Pt 2","key":"10.1016\/j.resinv.2022.11.002_bib4","first-page":"e119","article-title":"Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals \u2018occult\u2019 asthma of childhood","volume":"22","author":"Hasegawa","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1086\/313937","article-title":"Spectrum of clinical illness in hospitalized patients with \u201ccommon cold\u201d virus infections","volume":"31","author":"El-Sahly","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib6","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JCM.00636-10","article-title":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method","volume":"48","author":"Gaunt","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/520816","article-title":"Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity","volume":"196","author":"Kistler","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI1355","article-title":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense","volume":"101","author":"Hayden","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2022.11.002_bib11","first-page":"p.1086","article-title":"Respiratory syncytial virus and metapneumovirus","author":"Collins","year":"2013"},{"key":"10.1016\/j.resinv.2022.11.002_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-3476(79)80647-2","article-title":"The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice","volume":"95","author":"Henderson","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.resinv.2022.11.002_bib13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/bmj.307.6910.982","article-title":"Respiratory viruses and exacerbations of asthma in adults","volume":"307","author":"Nicholson","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2022.11.002_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.1974.03230160020004","article-title":"Viruses as precipitants of asthmatic attacks in children","volume":"227","author":"Minor","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2022.11.002_bib17","first-page":"149","article-title":"Rhinovirus and influenza type A infections as precipitants of asthma","volume":"113","author":"Minor","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9-11 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2022.11.002_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1034\/j.1399-3003.2000.16d19.x","article-title":"Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease","volume":"16","author":"Seemungal","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2022.11.002_bib20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/thorax.58.1.37","article-title":"Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study","volume":"58","author":"Rohde","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2022.11.002_bib22","doi-asserted-by":"crossref","first-page":"170103","DOI":"10.1183\/16000617.0103-2017","article-title":"Exacerbations of COPD","volume":"27","author":"Viniol","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2022.11.002_bib23","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1378\/chest.14-1961","article-title":"The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study","volume":"147","author":"Gao","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2022.11.002_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.202105-1137LE","article-title":"The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study","volume":"204","author":"Crichton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.resinv.2020.06.006","article-title":"Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan","volume":"58","author":"On","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2022.11.002_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.11150\/kansenshogakuzasshi1970.66.790","article-title":"Three cases of lower respiratory tract infection worsened after rhinovirus infection","volume":"66","author":"Konishi","year":"1992","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.resinv.2022.11.002_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resp.2014.07.010","article-title":"Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium","volume":"202","author":"Yamaya","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI118067","article-title":"Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure","volume":"96","author":"Subauste","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2022.11.002_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI118431","article-title":"Rhinovirus stimulation of interleukin-6 in\u00a0vivo and in\u00a0vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation","volume":"97","author":"Zhu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2022.11.002_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.resp.2005.11.006","article-title":"Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells","volume":"154","author":"Inoue","year":"2006","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.anai.2022.01.007","article-title":"Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity","volume":"128","author":"Feng","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib32","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1172\/JCI117581","article-title":"A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects","volume":"94","author":"Calhoun","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.resinv.2022.11.002_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1165\/rcmb.2005-0385OC","article-title":"Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells","volume":"34","author":"Edwards","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2022.11.002_bib34","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1365-2222.2009.03307.x","article-title":"Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus","volume":"39","author":"Skevaki","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2022.11.002_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.resinv.2014.03.004","article-title":"Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells","volume":"52","author":"Yamaya","year":"2014","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2022.11.002_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2022.11.002_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.00065111","article-title":"Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2022.11.002_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09031936.06.00058505","article-title":"Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells","volume":"28","author":"Yasuda","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2022.11.002_bib39","series-title":"GOLD report. Global strategy for prevention, diagnosis, and management of COPD: 2022 report","year":"2022"},{"key":"10.1016\/j.resinv.2022.11.002_bib40","series-title":"National institutes of health, national heart, lung, and blood institute. Global initiative for asthma","year":"2022"},{"key":"10.1016\/j.resinv.2022.11.002_bib41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1532-5415.2005.00592_9.x","article-title":"Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"54","author":"Yasuda","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.resinv.2022.11.002_bib42","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1532-5415.2007.01373.x","article-title":"PEACE Study Group. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease","volume":"55","author":"Tatsumi","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.resinv.2022.11.002_bib43","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","article-title":"Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomized placebo-controlled study","volume":"371","author":"Zheng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2022.11.002_bib44","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","article-title":"Ambroxol in the 21st century: pharmacological and clinical update","volume":"4","author":"Malerba","year":"2008","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.resinv.2022.11.002_bib45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/15412555.2017.1347918","article-title":"Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis","volume":"14","author":"Cazzola","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.resinv.2022.11.002_bib46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/02770903.2012.717657","article-title":"Patients with asthma benefit from concomitant therapy with cineole: a placebo-controlled, double-blind trial","volume":"49","author":"Worth","year":"2012","journal-title":"J Asthma"},{"key":"10.1016\/j.resinv.2022.11.002_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jmv.23974","article-title":"The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium","volume":"87","author":"Yamaya","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.706901","article-title":"Remdesivir and cyclosporine synergistically inhibit the human coronaviruses OC43 and SARS-CoV-2","volume":"12","author":"Hsu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","article-title":"SARS-CoV-2 infection is effectively treated and prevented by EIDO-2801","volume":"591","author":"Wahl","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.resinv.2022.11.002_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1183\/09031936.00208011","article-title":"Macrolide effects on the prevention of COPD exacerbations","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2022.11.002_bib51","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.chest.2018.10.027","volume":"155","author":"McShane","year":"2019","journal-title":"Bronchiectasis. Chest"},{"key":"10.1016\/j.resinv.2022.11.002_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1532-5415.2009.02034.x","article-title":"Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease","volume":"57","author":"Tatsumi","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.resinv.2022.11.002_bib54","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/pharmaceutics14061135","article-title":"Post-COVID Syndrome: the research progress in the treatment of pulmonary sequelae after COVID-19 infection","volume":"14","author":"Ruggiero","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.resinv.2022.11.002_bib55","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","article-title":"Viral pneumonia","volume":"377","author":"Ruuskanen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2022.11.002_bib56","doi-asserted-by":"crossref","first-page":"O578","DOI":"10.1111\/1469-0691.12525","article-title":"Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011-2012","volume":"20","author":"Ambrosioni","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2022.11.002_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","article-title":"The common cold","volume":"361","author":"Heikkinen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2022.11.002_bib58","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/infdis\/jiaa029","article-title":"Respiratory syncytial virus antivirals: problems and progress","volume":"222","author":"Hayden","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib59","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0140-6736(01)06528-X","article-title":"Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study","volume":"358","author":"Zambon","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2022.11.002_bib60","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1378\/chest.100.5.1377","article-title":"Respiratory syncytial virus infection among intubated adults in a university medical intensive care unit","volume":"100","author":"Guidry","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2022.11.002_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy316","article-title":"Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults \u226560 years old","volume":"5","author":"Belongia","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib62","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.chest.2020.06.006","article-title":"Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes","volume":"158","author":"Price","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2022.11.002_bib63","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10875-020-00949-6","article-title":"Cytokine profiles before and after immune modulation in hospitalized patients with COVID-19","volume":"41","author":"Azmy","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib64","first-page":"117","article-title":"Association of RANTES with the replication of severe acute respiratory syndrome coronavirus in THP-1 cells","volume":"10","author":"Li","year":"2005","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jmv.20556","article-title":"Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections","volume":"78","author":"Okabayashi","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/ajrccm.163.2.2003122","article-title":"Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease","volume":"163","author":"Aaron","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib67","article-title":"Detection of respiratory viruses and expression of inflammatory cytokines in patients with acute exacerbation chronic obstructive pulmonary disease in Mongolia China","volume":"82","author":"Feng","year":"2021","journal-title":"Braz J Biol"},{"key":"10.1016\/j.resinv.2022.11.002_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.109.162149","article-title":"Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells","volume":"333","author":"Yamaya","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.resinv.2022.11.002_bib69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pupt.2015.07.001","article-title":"The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells","volume":"33","author":"Yamaya","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resinv.2022.11.002_bib70","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1038\/srep07176","article-title":"Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon","volume":"4","author":"Thomas","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2022.11.002_bib71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2009.08.025","article-title":"N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus","volume":"79","author":"Geiler","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib72","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","article-title":"N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)","volume":"82","author":"Mata","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10517-017-3678-1","article-title":"Study of SMAD-dependent signal pathway in the development of early pulmonary fibrosis in mice infected with influenza A\/H1N1 virus","volume":"162","author":"Shatskaya","year":"2017","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib74","article-title":"H1N1 influenza virus-infected nasal mucosal epithelial progenitor cells promote dendritic cell recruitment and maturation","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02778986","article-title":"Reactive oxygen species and nitric oxide in viral diseases","volume":"56","author":"Peterhans","year":"1997","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092101","article-title":"Selenium, selenoproteins and viral infection","volume":"11","author":"Guillin","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.resinv.2022.11.002_bib77","article-title":"Reactive oxygen species associated immunoregulation post influenza virus infection","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009124","article-title":"Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation","volume":"6","author":"Beale","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.resinv.2022.11.002_bib79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000327434","article-title":"Differential effects of corticosteroids on serum eosinophil cationic protein and cytokine production in rhinovirus- and respiratory syncytial virus-induced acute exacerbation of childhood asthma","volume":"155","author":"Kato","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib80","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/j.1399-3038.2010.01026.x","article-title":"Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing","volume":"22","author":"Kato","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.resinv.2022.11.002_bib81","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib82","first-page":"L749","article-title":"Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1\u03b2","volume":"273","author":"Terajima","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib83","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1074\/jbc.M701325200","article-title":"Corticosteroids and \u03b22 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements","volume":"282","author":"Edwards","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2022.11.002_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198548","article-title":"The proton ATPase inhibitor bafilomycin A1 reduces the release of rhinovirus C and cytokines from primary cultures of human nasal epithelial cells","volume":"304","author":"Yamaya","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib85","first-page":"L362","article-title":"Infection of human respiratory submucosal glands with rhinovirus: effects on cytokine and ICAM-1 production","volume":"277","author":"Yamaya","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib86","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1128\/JVI.79.19.12273-12279.2005","article-title":"Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells","volume":"79","author":"Hewson","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib87","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2500\/ajra.2009.23.3407","article-title":"Cigarette smoke extract enhances rhinovirus-induced toll-like receptor 3 expression and interleukin-8 secretion in A549 cells","volume":"23","author":"Wang","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.resinv.2022.11.002_bib88","doi-asserted-by":"crossref","first-page":"278,","DOI":"10.3389\/fcimb.2020.00278","article-title":"Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells","volume":"10","author":"Wang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12931-016-0438-0","article-title":"Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium","volume":"17","author":"Shishikura","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib90","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000151729","article-title":"Tiotropium bromide attenuates respiratory syncytial virus replication in epithelial cells","volume":"76","author":"Iesato","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2022.11.002_bib91","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2009.05.003","article-title":"Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells","volume":"83","author":"Asada","year":"2009","journal-title":"Antivir Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib92","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00563-2019","article-title":"Current perspectives on the role of interleukin-1 signaling in the pathogenesis of asthma and COPD","volume":"55","author":"Osei","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2022.11.002_bib93","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620933508","article-title":"Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications","volume":"14","author":"Pelaia","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155593","article-title":"The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?","volume":"144","author":"Morris","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.resinv.2022.11.002_bib95","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.resinv.2022.11.002_bib96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.resinv.2022.11.002_bib97","first-page":"L413","article-title":"Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases","volume":"264","author":"Richman-Eisenstat","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib98","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.123.4.1240","article-title":"Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4","volume":"123","author":"Beeh","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2022.11.002_bib99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000196514","article-title":"Interleukin 1\u03b2, tumor necrosis factor \u03b1, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy","volume":"63","author":"Sakito","year":"1996","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2022.11.002_bib100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virol.2015.03.048","article-title":"Rig-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells","volume":"482","author":"Wu","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.resinv.2022.11.002_bib101","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1182\/blood-2008-01-132860","article-title":"Toll-like receptor-mediated activation of neutrophils by influenza A virus","volume":"112","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2022.11.002_bib102","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/156652408785161032","article-title":"Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma","volume":"8","author":"Kuperman","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib103","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomized dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib104","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1365-2222.2006.02566.x","article-title":"Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors","volume":"36","author":"Volonaki","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2022.11.002_bib105","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1007\/s11033-020-05831-7","article-title":"Intussusceptive angiogenesis in COVID-19: hypothesis on the significance and focus on the possible role of FGF2","volume":"47","author":"Meini","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.resinv.2022.11.002_bib106","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yexmp.2013.03.007","article-title":"Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A\/H1N1 virus infection","volume":"94","author":"Bautista","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.resinv.2022.11.002_bib107","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2741\/4077","article-title":"TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2\/ERK pathway","volume":"17","author":"Xiao","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.resinv.2022.11.002_bib108","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1165\/ajrcmb.22.6.3779","article-title":"Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema","volume":"22","author":"Kaner","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2022.11.002_bib109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0891-5849(90)90034-G","article-title":"Reactive oxygen species and airway inflammation","volume":"9","author":"Barnes","year":"1990","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib110","first-page":"L284","article-title":"Oxidants affect permeability and repair of the cultured human tracheal epithelium","volume":"268","author":"Yamaya","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib111","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(01)01324-3","article-title":"Reactive nitrogen and oxygen species in airway inflammation","volume":"429","author":"Folkerts","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib112","doi-asserted-by":"crossref","first-page":"23633","DOI":"10.1002\/jcp.28931","article-title":"Reactive oxygen species are involved in eosinophil extracellular traps release and in airway inflammation in asthma","volume":"234","author":"Silveira","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12967-020-02573-9","article-title":"Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial","volume":"18","author":"Perrone","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib114","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/ijms22063059","article-title":"Therapeutic role of tocilizumab in SARS-CoV-2-induced cytokine storm: rationale and current evidence","volume":"22","author":"Pelaia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2022.11.002_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102512","article-title":"Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab","volume":"114","author":"Morrison","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.resinv.2022.11.002_bib116","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/jmv.25964","article-title":"Tocilizumab for the treatment of severe coronavirus disease 2019","volume":"92","author":"Alattar","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib117","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2022.11.002_bib118","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe COVID-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib119","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1093\/cid\/ciac014","article-title":"Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of coronavirus disease 2019 (COVID-19) patients requiring supplemental O2 therapy: a prospective controlled nonrandomized study","volume":"75","author":"Marrone","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib120","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1002\/jmv.27768","article-title":"Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: a case-control study","volume":"94","author":"Boglione","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib121","first-page":"211","article-title":"Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study","volume":"30","author":"Dezza","year":"2022","journal-title":"Inf Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib122","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib123","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib124","article-title":"COVID-19: molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2022.11.002_bib125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.7326\/M22-0729","article-title":"Effect of molnupiravir on biomarkers, respiratory interventions, and medical services in COVID-19: a randomized, placebo-controlled trial","volume":"175","author":"Johnson","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib126","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib127","article-title":"Inhaled corticosteroids for the treatment of COVID-19","volume":"3","author":"Griesel","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resinv.2022.11.002_bib128","article-title":"Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2022.11.002_bib129","article-title":"Dexamethasone vs methylprednisolone high dose for COVID-19 pneumonia","volume":"16","author":"Prinz\u00f3n","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2022.11.002_bib130","first-page":"323","article-title":"High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells","volume":"15","author":"Cinatl","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13075-020-02395-6","article-title":"Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis","volume":"22","author":"Favalli","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2022.11.002_bib132","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib133","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00134-009-1727-6","article-title":"H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment","volume":"36","author":"Quispe-Laime","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib134","article-title":"Corticosteroid treatment ameliorates acute lung injury induced by 2009 swine origin influenza A (H1N1) virus in mice","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2022.11.002_bib135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/jpet.116.232009","article-title":"Tiotropium attenuates virus-induced pulmonary inflammation in cigarette smoke-exposed mice","volume":"357","author":"Bucher","year":"2016","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.resinv.2022.11.002_bib136","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome","volume":"183","author":"Brun-Buisson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib137","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201101-0110OC","article-title":"Korean Society of Critical Care Medicine H1N1 Collaborative. Corticosteroid treatment in critically ill patients with pandemic influenza A\/H1N1 2009 infection: analytic strategy using propensity scores","volume":"183","author":"Kim","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib138","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1021\/bi00155a013","article-title":"Binding of influenza hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography","volume":"31","author":"Sauter","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.resinv.2022.11.002_bib139","doi-asserted-by":"crossref","first-page":"17869","DOI":"10.1074\/jbc.M000217200","article-title":"Cloning and expression of the human N-acetylneuraminic acid phosphate synthase gene with 2-keto-3-deoxy-D-glycero- D-galacto-nononic acid biosynthetic ability","volume":"275","author":"Lawrence","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2022.11.002_bib140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/314938","article-title":"Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment","volume":"180","author":"Fritz","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib141","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2022.11.002_bib142","first-page":"924","article-title":"Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages","volume":"58","author":"Kacergius","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.resinv.2022.11.002_bib143","first-page":"L160","article-title":"Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells","volume":"299","author":"Yamaya","year":"2010","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib144","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cimid.2017.11.002","article-title":"Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus","volume":"56","author":"Takahashi","year":"2018","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib145","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1128\/JVI.01207-12","volume":"86","author":"Takahashi","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.resinv.2022.11.002_bib146","first-page":"L560","article-title":"Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells","volume":"278","author":"Suzuki","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib147","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejphar.2010.09.056","article-title":"Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells","volume":"650","author":"Yamaya","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib148","article-title":"Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells","volume":"1","author":"Yamaya","year":"2013","journal-title":"Phys Rep"},{"key":"10.1016\/j.resinv.2022.11.002_bib149","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s12272-013-0210-7","article-title":"Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells","volume":"37","author":"Yamaya","year":"2014","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/iid3.102","article-title":"Increased rhinovirus replication in nasal mucosa cells in allergic subjects is associated with increased ICAM-1 levels and endosomal acidification and is inhibited by L-carbocisteine","volume":"4","author":"Yamaya","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.resinv.2022.11.002_bib151","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12931-018-0752-9","article-title":"Oxidative stress enhances the expression of IL-33 in human airway epithelial cells","volume":"19","author":"Aizawa","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib152","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1164\/ajrccm.165.8.2103094","article-title":"Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells","volume":"165","author":"Suzuki","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.11.002_bib153","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12272-017-0950-x","article-title":"Clarithromycin decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma: effects on IL-6, IL-8 and IL-33","volume":"43","author":"Yamaya","year":"2020","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.resinv.2022.11.002_bib154","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1440-1843.2007.01227.x","article-title":"Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14","volume":"13","author":"Inoue","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2022.11.002_bib155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/sj.bjp.0707135","article-title":"Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells","volume":"150","author":"Yamaya","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.687818","article-title":"Kakkonto inhibits cytokine production induced by rhinovirus infection in primary cultures of human nasal epithelial cells","volume":"12","author":"Saito","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.resinv.2022.11.002_bib157","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.resp.2011.10.017","article-title":"L-carbocisteine inhibits respiratory syncytial virus infection in human tracheal epithelial cells","volume":"180","author":"Asada","year":"2012","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.resinv.2022.11.002_bib158","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.phrs.2016.07.033","article-title":"Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3","volume":"111","author":"Yamamoto","year":"2016","journal-title":"Pharmacol Res"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534522001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534522001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:13Z","timestamp":1761949993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534522001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":158,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2212534522001538"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2022.11.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}